• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconweight-loss and diet control industry

weight-loss and diet control industry

Page 4 of 10
How intermittent fasting could help boost your work performance
Life
How intermittent fasting could help boost your work performance
By Sonya CollinsAugust 11, 2024
Lars Fruergaard Jorgensen
Health
Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By BloombergAugust 7, 2024
Thomas Schinecker, chief executive officer of Roche
Finance
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
Obesity medicine physician Dr. Nisha Patel breaks down five weight loss myths that “need to die” with Fortune.
Health
The 5 biggest weight loss myths that ‘need to die,’ according to an obesity doctor
By Lindsey LeakeJuly 18, 2024
Danone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss
Health
Danone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss
By Dasha Afanasieva, Deena Shanker and BloombergJune 24, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
Retail
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
Higher amounts of the low-calorie sweetener xylitol, often marketed as a healthy sugar substitute, is linked to an increased risk of cardiovascular events such as stroke and heart attack, according to a new Cleveland Clinic study.
Health
Sugar substitute xylitol may increase your risk of heart attack and stroke, new study shows. What to know about the low-calorie sweetener
By Lindsey LeakeJune 14, 2024
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
Newsletters
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
By Emma Hinchliffe and Joey AbramsJune 11, 2024
Dr. Razia Hashmi, vice president of clinical affairs, Blue Cross Blue Shield Association, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., on Tuesday, May 21, 2024.
Health
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
Nestle CEO Mark Schneider
Retail
Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By Sasha RogelbergMay 21, 2024
Dr. Patrick Carroll (right), Hims & Hers chief medical officer, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., Monday, May 20, 2024.
Conferences
Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By Marco Quiroz-GutierrezMay 20, 2024
woman shows off old oversized jeans
Health
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By Madison Muller, Jessica Nix and BloombergMay 20, 2024
woman measures her waist
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
New York outlaws sales of diet pills and muscle-mass builders to children
Retail
New York outlaws sales of diet pills and muscle-mass builders to children
By Maysoon Khan and The Associated PressApril 25, 2024
1
  • 2
  • 3
  • 4
  • 5
  • 6
...10
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.